Reagent with DAPI (Invitrogen). Images were collected using a Nikon Eclipse 90i microscope. Average cell area was quantified using Volocity software (PerkinElmer). Co-localization analysis was performed using the coloc2 plugin in the FIJI version of ImageJ.
Immunofluorescence analysis of P. berghei blood stage parasites was carried out as previously described (6) with a few modifications (7) . Infected red blood cells were fixed on slides in 4% paraformaldehyde and 0.0075% glutaraldehyde. Cells were permeabilized with 0.1% triton X-100 in PBS, after which unreacted aldehydes were reduced by treatment with 0.1 g/L NaBH 4 . Slides were blocked and probed in 3% BSA in PBS. Cells were mounted with Prolong Gold Antifade Reagent with DAPI (Invitrogen), and sealed with a coverslip. Images were collected using a Nikon Eclipse 90i microscope.
P. falciparum transfections
To construct the vector pLNCaM-ACC 115 -GFP, nucleotides encoding the first 115 residues of the PfACC gene (PlasmoDB PF3D7_1469600, GenBank XM_001348802) were amplified from cDNA of P. falciparum 3D7 erythrocyte stages with primers PfACCF and PfACCR (Table S2 ) and the amplicon was inserted into the pLNCaM vector (pLN-ENR-GFP, GenBank DQ813653) (8) using the restriction sites AvrII and BsiWI. To construct the vector pLNCaM-HCS1-GFP, the full length PfHCS1 gene (PlasmoDB PF3D7_1026900, GenBank XM_002585368) was amplified with the primers PfHCS1F and PfHCS1R (Table S2 ) and inserted into pLNCaM. To construct the vector pLNCaM-HCS2-GFP, the full length PfHCS2 gene (PlasmoDB PF3D7_1460000, GenBank XM_001348711) was amplified with the primers PfHCS2F and PfHCS2R (Table   S2 ) and inserted into pLNCaM.
To generate two different expression levels of BCCP in parasites, we made use of a lowerstrength promoter, the ribosomal protein L2 promoter (9) , in addition to the calmodulin promoter. To construct the vectors pLNCaM-BCCP-GFP and pLNRL2-BCCP-GFP, a 79-residue fragment from the BCCP domain of PfACC (residues 1156-1369) was amplified with the primers BCCPF and BCCPR (Table S2) , and inserted into the respective vectors using the restriction sites AvrII and BsiWI. To construct the vector pLNRL2-ACP 55 -BCCP-GFP, the first 55 residues of the PfACP gene (PlasmoDB PF3D7_0208500, GenBank XM_001349559) were amplified with primers ACPF and ACPR (Table S2 ) and inserted into a pBluescriptlike subcloning vector (pGA4) using the restriction sites AvrII and NheI. The BCCP fragment of PfACC was then amplified from the pLNCaM-BCCP-GFP plasmid with primers BCCPF2 and BCCPR (Table S2 ) and inserted into the pGA4-ACP 55 vector using the restriction sites NheI and BsiWI. The resulting pGA4-ACP 55 -BCCP plasmid was digested with AvrII and BsiWI and the PfACP 55 -BCCP construct was inserted into pLNRL2.
Parasite transfections were carried out using the mycobacteriophage Bxb1 integrase system developed by Nkrumah et. al. (8) and modified by Spalding et. al. (10) . Red blood cells were preloaded with 50-100 µg DNA and then infected with Dd2 attB parasites. In each case, red blood cells were cotransfected with one of the insertion vectors (containing the transgene, the attP recombination site, and the blasticidin-S-deamidase resistance marker) and the pINT plasmid (containing the integrase gene).
The integrase facilitates single-crossover recombination between the attP site on the plasmid and an attB site which has previously been integrated into the cg6 locus of the P. falciparum genome. This method results in site-specific, stable integration of a single copy of the transgene into the parasite genome. Integration was confirmed by PCR.
Immunofluorescence analysis and live fluorescence microscopy of P. falciparum parasites
Immunofluorescence analysis of P. falciparum blood stage parasites was carried out as previously described (6) with a few modifications (7). Parasites were fixed on slides in 4% paraformaldehyde and 0.0075% glutaraldehyde, after which cells were permeabilized with 0.1% triton X-100 in PBS. Unreacted aldehydes were reduced by treatment with NaBH 4 , and cells were blocked and probed in 3% BSA in PBS.
Cells were treated with Prolong Gold Anti-Fade with DAPI (Invitrogen), and sealed with a coverslip.
Images were collected using a Nikon Eclipse 90i (BCCP, biotin, SA-HRP) or Nikon E800 microscope (ACC).
For live fluorescence images, parasites were incubated for 30 minutes with 200 nM Mitotracker CMX-Ros (Invitrogen) and 1 μg/mL DAPI. The cells were washed by incubating for 5 minutes in RPMI before mounting on glass slides. Images were collected using a Nikon Eclipse 90i (BCCP) or Nikon E800 microscope (ACC, HCS).
Endogenous tagging and localization of P. berghei biotin ligases
Single cross-over replacement constructs were made for GFP tagging of the P. berghei biotin ligase genes HCS1 (PBANKA_051100) and HCS2 (PBANKA_132360). P. berghei ANKA genomic DNA was amplified with primer pairs PbHCS1F/PbHCS1R and PbHCS2F/PbHCS2R (Table S2) , TOPO-TA cloned into pCR2.1 (Invitrogen), and sequenced to confirm sequence fidelity. The inserts were cloned into the BglII/AvrII sites of p3REP, a construct created by combining pL0006 (MRA-775, MR4, ATCC Manassas Virginia) with the AvrII/SmaI fragment of ef1α-PfKAHRP-GFP (11) to yield a fusion of GFP-CAM3' to the 3' end of the gene of interest in a construct using human DHFR selection. Constructs were linearized with BstEII and BglII, respectively, and transfected into P. berghei ANKA according to Janse and coworkers (12) . 
Biotin ligase activity assays and affinity/western blot analysis
The biotin ligase genes were subcloned into expression vector pMALcHT (14) using restriction sites BamHI and PstI. To construct vectors pMALcHT-HCS1 and pMALcHT-HCS2, the full length genes were amplified either with primer pair MAL1F and MAL1R or primer pair MAL2F and MAL2R (Table S2) For the cell-free assay, infected red blood cells were lysed in 0.2% saponin in PBS for 3 minutes at room temperature, then diluted with 10 mL ice-cold PBS and centrifuged in a swinging-bucket rotor at 3,600 g for 10 minutes at 4°C. The parasite pellets were washed twice in 10 mL ice-cold PBS and centrifuged as above, then frozen at -80°C. The parasites were resuspended in reaction buffer (100 mM Na/K phosphate and 150 mM NaCl at pH 7.5) and sonicated at 10% amplitude for 3×1 minute with a 0.5 second pulse, on ice. Parasite whole cell extracts were normalized by total protein and incubated with 10 µM BCCP, 200 µM biotin, 5 mM ATP, 2 mM DTT and EDTA-free protease inhibitor cocktail (Roche) at 37°C for 2 hours. The reaction was quenched by adding 4×NuPAGE loading buffer and heating at 95°C for 5 minutes. Samples were analyzed by streptavidin affinity blotting and BCCP western blotting, as described above.
Growth assay and incorporation of radiolabeled biotin in biotin-depleted media
Biotin-depleted medium was prepared using RPMI 1640 medium modified with L-glutamine, without phenol red and biotin (US Biological R9002-01), which was supplemented with 25 mM HEPES, 0.375% sodium bicarbonate, 12.5 µg/mL hypoxanthine, 5 g/L Albumax II, and 25 µg/mL gentamicin. The cultures were normalized to 0.1% parasitemia and 2% hematocrit. For each parasite line, the cultures and red blood cells were washed twice in 10 mL biotin-free RPMI to remove biotin, and then divided into two wells of a six-well plate, and cultured either in the biotin-depleted media, or the same media with biotin added back to 200 µg/L (the concentration found in RPMI medium). Slides were prepared every other day to monitor parasite growth, and parasites were harvested on day eight of the growth assay for western blot analysis.
The lipid-free BSA (Sigma) was prepared as a 600 µM stock solution in Dubecco's PBS. Palmitic acid (Sigma) and potassium oleate (Fluka) were dissolved in ethanol as 30 mM stock solutions.
Reconstituted lipid-associated BSA was prepared by adding lipid stock solutions to the lipid-free BSA and incubating at 4°C for 3-6 days. Complete medium was prepared with biotin-free RPMI, 25 mM HEPES, 0.375% sodium bicarbonate, 12.5 µg/mL hypoxanthine, and 25 µg/mL gentamicin. The final concentrations of lipid-free BSA and each fatty acid in the medium was 30 µM. The growth assay was performed as above.
For radioactive biotin incorporation experiments, P. falciparum cultures were maintained in 5 mL cultures at 2% hematocrit with daily feedings of biotin-free medium. Cultures at 1% parasitemia were labeled with 0.48 nmol (2.55 million CPM) Radiolabeled fatty acids were detected using a phosphoimager. Acetate incorporation experiments were conducted using biotin-free medium as well as the minimal fatty acid medium (palmitate and oleate) described above.
P. berghei biotin ligase knockouts
In order to generate the double cross-over knockout construct for PbHCS1 and PbHCS2, homology arms composed of the 5' and 3' UTR of PbHCS1 and PbHCS2 were cloned into the pDEF-hDHFR plasmid (16) .
Between 800 and 1000 bp of the 5' UTR of PbHCS1 and PbHCS2 were amplified from P. berghei genomic DNA with primer pairs PbHCS1ko5F/PbHCS1ko5R and PbHCS2ko5F/PbHCS2ko5R (Table S2 ) and inserted into the HindIII/PstI site of pDEF-hDHFR (which was modified to also contain an XhoI site). Between 800
and 900 bp of the 3' UTR of PbHCS1 and PbHCS2 were amplified from P. berghei genomic DNA with primer pairs PbHCS1ko3F/PbHCS1ko3R and PbHCS2ko3F/PbHCS2ko3R (Table S2 ) and inserted into the KpnI/EcoRI site of pDEF-hDHFR. All plasmids were sequence verified prior to use. Constructs were linearized with XhoI/EcoRI or HindIII/EcoRI and transfected into P. berghei ANKA-GFP 507c1 (17) according to Janse and coworkers (12) , with a few modifications. Briefly, P. berghei parasites were collected from Swiss Webster mice and cultured overnight to obtain mature schizonts. Schizonts were purified using a Nycodenz density gradient and electroporated with 10 µg of DNA using the Amaxa
Nucleofector. Selection and cloning by limiting dilution were performed as described (12) . Integration of the construct at the correct genomic locus and removal of the targeted gene was confirmed by PCR analysis. Two clones for ΔPbHCS2 and four clones from two transfections for ΔPbHCS1 were isolated for analysis.
Prepatency assay
In order to determine the in vivo infectivity of the biotin ligase knockout parasites compared to wildtype controls, salivary gland sporozoites were harvested from infected A. stephensi mosquitoes and injected into mice intravenously at 500 or 5000 sporozoites per mouse. Parasitemia was monitored daily by blood smear. The prepatent period represents the average time (in days) from sporozoite injection until microscopic detection of blood stage parasites. The average was calculated only from mice that developed a patent infection. At the conclusion of the experiment, blood was collected from one mouse per group, parasite gDNA was extracted, and the mutant or wild-type genotype was confirmed by PCR.
Merosome assay
As an in vitro measure of infectivity, we also measured the production of merosomes in ΔHCS1 parasites compared to wild-type. HepG2 cells were seeded at a density of 1×10 5 
Merosome infection assay
Wild-type and ΔHCS1 sporozoites were used to produce merosomes in HepG2 cells grown under biotin deficient or biotin replete conditions, as described above. Harvested merosomes were quickly quantified in a hemocytometer and suspended in 200 µL of DMEM medium for tail vein injection into mice. Blood stage parasitemia was monitored daily by microscopy to determine the prepatent period. In two repeat experiments (experiments 2-3 in Table 2 ), higher yields of merosomes allowed us to use a larger inoculum and larger cohorts of mice. Merosome samples were also used to quantify total merozoites injected using quantitative real-time PCR, as described above. Lysates from blood stage P. falciparum parasites over-expressing the biotin ligases (shown in figure 3) were analyzed by streptavidin affinity blotting (SA-HRP) to assess cellular biotinylation levels. Overexpressing PfHCS1, but not PfHCS2, results in a dramatic increase in biotinylation compared to the parental control (Dd2). Two different exposures of the same blot are shown. HSP70 was used as a loading control. Immunofluorescence analysis of HepG2 cells 48 hours post infection with wild-type or ΔHCS1 P. berghei.
Cells were cultured either with or without biotin, and protein biotinylation was assessed using αbiotin antibodies. The apicoplast is labeled with αACP and nuclei are illuminated with DAPI. Scale bars = 5 µm.
